ADCNF(ADCNF)
USD --+0.00%
Reward41Moderate
Risk44Moderate
📊75%Data
Thin 1% profit margin · Revenue down 6% YoY
ADCNF
+0.0 · +0.00%
USD · OTCGREY
ADCNF | Healthcare
Value Trap
Market Cap:466.60M
ℹ️
Reward Rating
41
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
44
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ADCNF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is ADCNF?

Adicon Holdings Limited, an investment holding company, provides medical testing services in the People's Republic of China.

ADCNF · Verdict

Moderate reward · moderate risk

ADCNF stands out on volatility and valuation, but watch the growth signal.

Based on 88% data coverage

ADCNF · Verdict

What’s working & what to watch

Strengths 2

  • Volatility95/100

    Top decile vs peers

  • Valuation84/100

    P/E 21.6× · PEG 0.37

Watchouts 3

  • Growth23/100

    Rev -4.8% CAGR · earnings -47.0%

  • Profitability34/100

    2% net margin · 1% ROE

  • Balance sheet41/100

    Current ratio 1.58

Model-based scoring. For information only — not financial advice.

What is ADCNF?

Adicon Holdings Limited, an investment holding company, provides medical testing services in the People's Republic of China. The company offers medical diagnostic testing services; testing services for research and development projects; and research and clinical trial services. The company is listed on the OTCGREY in USA, operating in the Healthcare sector, with a market capitalisation of 466.60M, and a P/E ratio of 65.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap466.60M
P/E Ratio65
Dividend YieldN/A
52 Week High0.65
52 Week Low0.65
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding718M
No. of Employees5,071
IndustryDiagnostics & Research
ExchangeOTCGREY
Beta0.257
CurrencyUSD · Reports in CNY